CRISPR-Cas Systems as Synthetic Biology Platforms in Cancer Management: A Critical Appraisal of Programmable Tools, Engineered Circuits and Clinical Evidence
Omeyiza Micheal Ibrahim, Afariogun Moses Sunday, Olugbiyi Emmanuel Adeogo, Aina Bamitale, Momoh Sokoato Isaac, Kehinde Sowunmi, Salawudeen Shuaibu Omeiza, Lukman Sadiq Onoruoiza & Arudi Gloria · Asian Journal of Biotechnology and Genetic Engineering · 2026
Background: Clustered regularly interspaced short palindromic repeats (CRISPR) and their associated (Cas) proteins are frequently described as a synthetic biology platform for oncology, yet the phrase conceals a wide range of very different engineering claims. Programmable nuclea...
Open access
Research Article
10.9734/ajbge/2026/v9i2200